| Titolo |
Pubblicato in |
Anno |
| Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management |
EUROPEAN JOURNAL OF NEUROLOGY |
2018 |
| Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach (Neurological Sciences, (2017), 38, 10, (1849-1858), 10.1007/s10072-017-3081-8) |
NEUROLOGICAL SCIENCES |
2018 |
| Role of cerebellar dentate functional connectivity in balance deficits in patients with multiple sclerosis |
RADIOLOGY |
2018 |
| Fingolimod vs dimethyl fumarate in multiple sclerosis. a real-world propensity score-matched study |
NEUROLOGY |
2018 |
| Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis. An Italian, Multicenter, Real-World Study |
CNS DRUGS |
2018 |
| Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis |
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY |
2018 |
| 2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes |
EUROPEAN JOURNAL OF NEUROLOGY |
2018 |
| Predicting the profile of increasing disability in multiple sclerosis |
MULTIPLE SCLEROSIS |
2018 |
| No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study |
JOURNAL OF NEUROLOGY |
2018 |
| Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online |
MULTIPLE SCLEROSIS AND RELATED DISORDERS |
2018 |
| Relation between functional connectivity and disability in multiple sclerosis. a non-linear model |
JOURNAL OF NEUROLOGY |
2018 |
| Prolonged-release fampridine in multiple sclerosis. clinical data and real-world experience. report of an expert meeting |
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS |
2018 |
| Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in relapsing-remitting Multiple sclerosis. an Italian real-word multicenter experience |
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS |
2018 |
| Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis |
NEW ENGLAND JOURNAL OF MEDICINE |
2018 |
| Pregnancy decision-making in women with multiple sclerosis treated with natalizumab. iI maternal risks |
NEUROLOGY |
2018 |
| Dentate nucleus connectivity in adult patients with multiple sclerosis: functional changes at rest and correlation with clinical features |
MULTIPLE SCLEROSIS |
2017 |
| Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis |
JOURNAL OF NEUROLOGY |
2017 |
| Effect on cognition of estroprogestins combined with Interferon Beta in multiple sclerosis: analysis of secondary outcomes from a randomised controlled trial |
CNS DRUGS |
2017 |
| Determinants of botulinum toxin discontinuation in multiple sclerosis. a retrospective study |
NEUROLOGICAL SCIENCES |
2017 |
| Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy |
NEUROLOGICAL SCIENCES |
2017 |
